1-3 of 3
Yuehui Wu
Close
Sort by
Journal Articles

Open-Label Pilot Study of Genetically Engineered NY-ESO-1 Specific T Cells (GSK3377794) Alone or in Combination with Pembrolizumab in Relapsed and Refractory Multiple Myeloma

Taiga Nishihori, MD, Jonathan L. Kaufman, MD, James E. Hoffman, Kristin Blouch, Sunil Pandit, Emily Butler, Amit Jain, Yuehui Wu, M. Phillip DeYoung, Aisha N. Hasan, Aaron P. Rapoport
Journal: Blood
Blood (2019) 134 (Supplement_1): 3134.
https://doi.org/10.1182/blood-2019-128059
Published: 2019
Journal Articles

A Phase I Study of GSK525762, a Selective Bromodomain (BRD) and Extra Terminal Protein (BET) Inhibitor: Results from Part 1 of Phase I/II Open Label Single Agent Study in Patients with Acute Myeloid Leukemia (AML)

Mark Dawson, MD PhD, Eytan M. Stein, MD, Brian J.P Huntly, Anastasios Karadimitris, PhD, Manali Kamdar, Carlos Fernandez de Larrea, Michael J. Dickinson, Paul Sung-Hao Yeh, MBBS, FRCPA, FRACP, Naval Daver, MD, Aristeidis Chaidos, MD PhD, Martin S. Tallman, MD, Raquel Jiménez, MD, Thierry Horner, PhD, January Baron, MS, John Brennan, Geraldine Ferron-Brady, Yuehui Wu, PhD, Natalie Karpinich, Brandon Kremer, Arindam Dhar, MBBS,MDPhD, Gautam Borthakur, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1377.
https://doi.org/10.1182/blood.V130.Suppl_1.1377.1377
Published: 2017
Journal Articles

Phase I/II Trial of the MEK1/2 Inhibitor Trametinib (GSK1120212) in Relapsed/Refractory Myeloid Malignancies: Evidence of Activity in Patients with RAS Mutation-Positive Disease

Gautam Borthakur, M.D., Leslie Popplewell, MD, Michael Boyiadzis, MD, MHSc, James M. Foran, MD, FRCPC, Uwe Platzbecker, MD, Norbert Vey, Walter B. Roland, MD, PhD, Rebecca L. Olin, MD, MS, Azra Raza, MD, Aristotles Giagounidis, MD, Oliver G. Ottmann, MD, Aref Al-Kali, MD, Elias J. Jabbour, MD, Tapan M. Kadia, M.D., Guillermo Garcia-Manero, MD, John W. Bauman, PhD, Yuehui Wu, PhD, Yuan Liu, Dan Schramek, John Z. Zhu, PhD, Paul Wissel, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2012) 120 (21): 677.
https://doi.org/10.1182/blood.V120.21.677.677
Published: 2012